What Idil Biotech does

Idil Biotech (legal name İdil Biotech) is a privately held medical diagnostic company headquartered in TÜBİTAK Marmara Teknokent, Gebze, Kocaeli, Turkey, founded in 2019 by individuals with more than 20 years of experience in molecular in vitro diagnostics. The company develops, manufactures, and markets real-time PCR (qPCR) diagnostic kits under the RevoDx brand, organized into clinically specific panels covering high-risk viral pathogens, sexually transmitted infections, respiratory infections, gastrointestinal pathogens, bacterial, viral, fungal, and protozoan infections, sepsis, meningitis/encephalitis, transplant, TORCH, tropical, herpes virus, and HLA genetic testing, alongside a SARS-CoV-2 dual-target kit. Its technology stack centers on probe- and dye-based qPCR compatible with most commercial real-time PCR instruments, paired with the DirEXT sub-brand of silica spin-column and magnetic-bead nucleic acid extraction reagents and a line of qPCR master mixes for research use. Manufacturing is conducted under ISO 13485 quality management in accordance with IVDD and IVDR, with CE-IVD marked products.

The company operates four revenue streams: (1) direct B2B sales of RevoDx diagnostic kits to clinical laboratories and hospital diagnostic departments (sold in standardized 100- or 500-test packages at undisclosed list prices via direct sales contact), (2) RevoDx/DirEXT purification and sample preparation kit sales, (3) contract manufacturing and outsourcing services for molecular diagnostic solutions (concept design, assay development, prototype and pilot batch production, validation and stability studies, technical documentation, CE submission assistance), and (4) OEM partnerships and technology transfer for products in its portfolio. Go-to-market is enterprise field sales supplemented by international trade show presence at Medlab Middle East, MEDICA, ECCMID, and Expomed Eurasia, and a product-catalog-driven company website. Customer concentration is not publicly disclosed; the named customer segments are clinical laboratories/hospitals (primary) and medical technology/biotechnology companies seeking outsourcing or OEM arrangements (secondary).

Name

Idil Biotech

Legal name

İdil Biotech

Website

https://idilbiotech.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Idil Biotech is a Turkey-based IVD manufacturer that develops and markets RevoDx real-time PCR diagnostic kits for infectious disease detection, serving clinical laboratories, hospitals, and medtech companies via direct B2B sales, OEM partnerships, and contract manufacturing.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics (In Vitro Diagnostics)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Molecular diagnostic kits
• Real-time PCR reagents
• Infectious disease detection
• In vitro diagnostics
• Nucleic acid extraction

Headquarters

HQ city

Istanbul

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Kit Sales: Sale of RevoDx brand molecular diagnostic kits for detection of various pathogens. Products are sold in test kit formats (typically 100 or 500 tests per kit) with catalog numbers for ordering.
2. Purification Kit Sales: Sale of nucleic acid extraction and purification kits for sample preparation in molecular diagnostics.
3. Outsourcing Services: Contract manufacturing and outsourcing services for molecular diagnostic solutions including assay design, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions.
4. OEM Partnership: Technology transfer and OEM partnership for products in the portfolio, allowing other companies to manufacture or distribute Idil Biotech products.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Idil Biotech develops, manufactures, and sells the RevoDx brand of real-time PCR (qPCR) molecular diagnostic kits for detection of infectious disease pathogens (viruses, bacteria, fungi, parasites) across panels for high-risk viral pathogens, STIs, respiratory, gastrointestinal, sepsis, meningitis/encephalitis, transplant, TORCH, tropical diseases, herpes, HLA genetics, and drug resistance. The company also markets DirEXT nucleic acid extraction/purification reagents, qPCR research master mixes, and offers contract manufacturing, assay development, validation, and OEM technology transfer services to other diagnostics companies.

Product overview

Idil Biotech is a medical diagnostic company providing high-value molecular diagnostic solutions for infectious diseases. The company's product portfolio centers on the RevoDx brand of real-time PCR (qPCR) diagnostic kits, encompassing over 100+ individual products organized into disease-specific categories. The portfolio includes: high-risk viral pathogen kits (HBV, HCV, HIV), sexually transmitted infection panels, respiratory pathogen panels (ranging from Respiratory-5 to Respiratory-34), gastrointestinal pathogen detection kits (bacterial, viral, parasitic), bacterial/viral/fungal/protozoan pathogen kits, drug resistance detection kits, herpes virus kits, HLA genetic testing kits, transplant pathogen panels, TORCH panels, sepsis and meningitis/encephalitis kits, tropical disease kits, SARS-CoV-2 kits, and sample preparation/purification products. The company also offers contract manufacturing and outsourcing services for molecular diagnostics development.

Differentiator

Problem solved

Functional benefit

Brands

• RevoDx: Molecular diagnostic product brand encompassing qPCR kits for infectious disease detection including viral, bacterial, fungal, and parasitic pathogens. Products include RevoDx SARS-CoV-2 qPCR Kit, RevoDx Respiratory-24 Pathogen Detection Kit, RevoDx Gastro Pathogen Detection Kit, RevoDx STI Pathogen Detection Kit, RevoDx Sepsis Pathogen Detection Kit, and many more diagnostic kits.
• DirEXT

Products and services

• RevoDx High Risk Viral Pathogen Detection Kits

Quantifiable outcome

• CMV qPCR Kit Limit of Detection: 56 IU/mL
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Medical Technology and Biotechnology CompaniescoreStrategic or Co-development PartnerIdil Biotech offers comprehensive outsourcing services for molecular diagnostic solutions to medical technology and biotechnology companies. Services include concept design, assay development, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions. Technology transfer of products in the portfolio is also possible.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Anatolia Geneworks: Turkey-based molecular diagnostics company offering a broad IVD/CE-marked qPCR menu for infectious disease pathogens, HLA typing, and HPV genotyping - the closest head-to-head peer to Idil Biotech given shared geography, technology platform, and target customer (clinical labs in EMEA/Middle East).
• Seegene: Korean molecular diagnostics specialist known for multiplex syndromic qPCR panels (respiratory, gastro, STI, meningitis/encephalitis) sold under its own brand and widely OEM-licensed - directly comparable to Idil's RevoDx multiplex pathogen panels on technology, menu, and OEM go-to-market model.
• Bioeksen R&D Technologies: Turkey-based molecular diagnostics company producing CE-IVD qPCR kits and rapid molecular platforms (including the COVID-era Rapid Molecular Detection System) - directly comparable given shared Turkish base, IVD/CE-IVD positioning, and infectious disease menu overlap with RevoDx.
• ELITech Group: European IVD manufacturer with a real-time PCR infectious disease menu, sample-preparation kits, and OEM/private-label capabilities - directly comparable to Idil on product architecture (qPCR kits + extraction reagents), CE-IVD positioning, and OEM contract manufacturing services.
• Sacace Biotechnologies: Italy-based molecular diagnostics company selling CE-IVD qPCR kits for infectious diseases (HBV, HCV, HIV, STI, respiratory, meningitis) plus OEM manufacturing services - closely comparable mid-sized European peer with similar menu breadth and OEM go-to-market.

Broad incumbents

• TIB Molbiol (Roche): Berlin-based molecular diagnostics specialist (now part of Roche Diagnostics) historically known for rapid development of qPCR assays for emerging pathogens and a deep infectious-disease menu - comparable on assay design philosophy and pathogen menu, though now distributed through Roche's global commercial engine.
• DiaSorin: Italian-headquartered diagnostics multinational with a molecular business spanning qPCR kits, sample-to-answer systems (LIAISON MDX), and OEM partnerships - comparable on molecular IVD menu and EMEA footprint, though operating at much larger scale with proprietary instrumentation.
• QIAGEN: Global molecular diagnostics and sample-preparation leader with the artus/QuantiFERON/QIAsymphony portfolio - overlaps with Idil on nucleic acid extraction kits (DirEXT vs QIAamp) and on parts of the infectious-disease qPCR menu, while operating at vastly larger scale through proprietary automation.

Emerging players

• Vircell (Amplifon group): Spain-based molecular diagnostics and microbiology company offering qPCR infectious-disease kits and OEM capabilities - comparable European mid-market peer with overlapping IVD/CE-IVD molecular menu and similar reliance on distribution partners.
• SolGent (KRIBB spinoff) / Kogene Biotech: Korean molecular diagnostics manufacturers producing CE-IVD/KFDA qPCR kits for infectious diseases (including SARS-CoV-2, respiratory, and enteric pathogens) and exporting globally - similar-sized Asian peers competing in the same overseas tender markets as Idil Biotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Idil Biotech